Diagnósticos da América S.A.

São Paulo Stock Exchange DASA3.SA

Diagnósticos da América S.A. EBITDA Margin for the year ending December 31, 2023: 15.49%

Diagnósticos da América S.A. EBITDA Margin is 15.49% for the year ending December 31, 2023, a -10.43% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Diagnósticos da América S.A. EBITDA Margin for the year ending December 31, 2022 was 17.30%, a 54.51% change year over year.
Diagnósticos da América S.A. EBITDA Margin for the year ending December 31, 2021 was 11.19%, a -12.62% change year over year.
Diagnósticos da América S.A. EBITDA Margin for the year ending December 31, 2020 was 12.81%, a -38.38% change year over year.
Diagnósticos da América S.A. EBITDA Margin for the year ending December 31, 2019 was 20.79%, a 26.43% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

São Paulo Stock Exchange: DASA3.SA

Diagnósticos da América S.A.

CEO	Mr. Licio Tavares Angelo Cintra
IPO Date	Nov. 19, 2004
Location	Brazil
Headquarters	Av. JuruA, 434
Employees	18,142
Sector	Industrials
Industries Professional Services Hospitals & Clinics Medical Instruments

Description

Diagnósticos da América S.A. provides diagnostic test services in Latin America. It offers approximately 3,000 types of examinations of clinical analyses and diagnostic imaging services. The company also provides support services to approximately 5,000 laboratories under the Alvaro brand, as well as operates for the public sector under the CientíficaLab brand. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 17, 2000. The company was founded in 1966 and is based in Barueri, Brazil.

Key trends

Past 5 years